Metabolic Abnormalities and Hepatocellular Carcinoma in Chinese Patients
Author Information
Author(s): Zhao Jinyan, Zhao Yunpeng, Wang Hao, Gu Xing, Ji Jun, Gao Chunfang
Primary Institution: Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China
Hypothesis
The study investigates the association between metabolic abnormalities and HBV-related hepatocellular carcinoma (HCC).
Conclusion
Metabolic abnormalities are closely associated with the occurrence and development of HBV-related HCC.
Supporting Evidence
- Higher GA level was strongly associated with increased risk of cancer compared to healthy controls.
- Serum triglycerides and LDL-C levels were negative contributory factors for HCC.
- HCC patients showed significantly higher levels of BMI and serum glucose than controls.
Takeaway
This study found that problems with metabolism can lead to liver cancer in people with hepatitis B.
Methodology
A cross-sectional study involving 179 HCC patients, 100 HBV carriers, and 150 healthy controls, with various metabolic and liver function tests conducted.
Potential Biases
Potential bias due to the selection of controls and the cross-sectional nature of the study.
Limitations
The study used HBV carriers as controls instead of chronic liver disease patients, and was limited to a clinical series rather than a community sample.
Participant Demographics
The study included 179 HCC patients, 100 HBV carriers, and 150 healthy controls, with a majority being male.
Statistical Information
P-Value
p<0.01
Confidence Interval
95% CI: 1.86~52.29
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website